J C Weeks

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Relationship between cancer patients' predictions of prognosis and their treatment preferences
    J C Weeks
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115 6084, USA
    JAMA 279:1709-14. 1998
  2. ncbi request reprint Use of breast-conserving surgery for treatment of stage I and stage II breast cancer
    E Guadagnoli
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 16:101-6. 1998
  3. ncbi request reprint Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer
    E Guadagnoli
    Health Care Policy, Department of Medicine, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 15:2338-44. 1997
  4. ncbi request reprint Predicting costs of stem-cell transplantation
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 18:64-71. 2000
  5. ncbi request reprint Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback
    E Guadagnoli
    Departmnent of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Breast Cancer Res Treat 61:171-5. 2000
  6. ncbi request reprint Who gets chemotherapy for metastatic lung cancer?
    C C Earle
    Center for Outcomes and Policy Research, Department of Adult Oncology Dana Farber Cancer Institute, Boston, MA 02115, USA
    Chest 117:1239-46. 2000
  7. ncbi request reprint Quality of breast cancer care in NCCN centers as assessed by the ASCO/NCCN quality measures: Overall performance and reasons for nonconcordance
    M E Hughes
    Dana Farber Cancer Institute, Boston, MA City of Hope National Medical Center, Duarte, CA Roswell Park, Buffalo, NY M D Anderson Cancer Center, Houston, TX Arthur G James Cancer Hospital, The Ohio State University, Columbus, OH University of Michigan Comprehensive Cancer Center, Ann Arbor, MI Fox Chase Cancer Center, Philadelphia, PA
    J Clin Oncol 27:6506. 2009
  8. ncbi request reprint Quality of informed consent in cancer clinical trials: a cross-sectional survey
    S Joffe
    Department of Paediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
    Lancet 358:1772-7. 2001
  9. ncbi request reprint Quality of informed consent: a new measure of understanding among research subjects
    S Joffe
    Department of Pediatrics, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Children's Hospital, Boston, USA
    J Natl Cancer Inst 93:139-47. 2001
  10. ncbi request reprint Recovery after stem-cell transplantation for hematologic diseases
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 19:242-52. 2001

Collaborators

Detail Information

Publications26

  1. ncbi request reprint Relationship between cancer patients' predictions of prognosis and their treatment preferences
    J C Weeks
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115 6084, USA
    JAMA 279:1709-14. 1998
    ....
  2. ncbi request reprint Use of breast-conserving surgery for treatment of stage I and stage II breast cancer
    E Guadagnoli
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 16:101-6. 1998
    ..To assess the use of breast-conserving surgery in two states reported to differ with respect to surgical treatment of breast cancer...
  3. ncbi request reprint Age-related patterns of care: evidence against ageism in the treatment of early-stage breast cancer
    E Guadagnoli
    Health Care Policy, Department of Medicine, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 15:2338-44. 1997
    ..To assess whether the use of adjuvant systemic therapy in postmenopausal women with early-stage breast cancer is influenced by patient age...
  4. ncbi request reprint Predicting costs of stem-cell transplantation
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 18:64-71. 2000
    ..We sought (1) to determine whether obtaining baseline information enabled identification of patients whose treatments would be the most costly and (2) to estimate inpatient costs for managing specific transplantation complications...
  5. ncbi request reprint Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback
    E Guadagnoli
    Departmnent of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Breast Cancer Res Treat 61:171-5. 2000
    ..001) from 33% to 17%, but a similar decrease was observed among control hospitals. Using medical opinion leaders to intervene in hospitals appeared as effective as performance feedback...
  6. ncbi request reprint Who gets chemotherapy for metastatic lung cancer?
    C C Earle
    Center for Outcomes and Policy Research, Department of Adult Oncology Dana Farber Cancer Institute, Boston, MA 02115, USA
    Chest 117:1239-46. 2000
    ..To determine the prevalence and factors associated with chemotherapy use in elderly patients presenting with advanced lung cancer...
  7. ncbi request reprint Quality of breast cancer care in NCCN centers as assessed by the ASCO/NCCN quality measures: Overall performance and reasons for nonconcordance
    M E Hughes
    Dana Farber Cancer Institute, Boston, MA City of Hope National Medical Center, Duarte, CA Roswell Park, Buffalo, NY M D Anderson Cancer Center, Houston, TX Arthur G James Cancer Hospital, The Ohio State University, Columbus, OH University of Michigan Comprehensive Cancer Center, Ann Arbor, MI Fox Chase Cancer Center, Philadelphia, PA
    J Clin Oncol 27:6506. 2009
    ..6506 Background: To assess the quality of breast cancer care in the National Comprehensive Cancer Network (NCCN), we compared practice against the ASCO/NCCN quality measures (QM)...
  8. ncbi request reprint Quality of informed consent in cancer clinical trials: a cross-sectional survey
    S Joffe
    Department of Paediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA
    Lancet 358:1772-7. 2001
    ..Efforts to educate providers and participants about the underlying goals of clinical trials are needed...
  9. ncbi request reprint Quality of informed consent: a new measure of understanding among research subjects
    S Joffe
    Department of Pediatrics, Dana-Farber Cancer Institute, and Division of Hematology/Oncology, Children's Hospital, Boston, USA
    J Natl Cancer Inst 93:139-47. 2001
    ..2 minutes to complete. CONCLUSIONS: The QuIC is a brief, reliable, and valid questionnaire that holds promise as a standardized way to assess the outcome of the informed consent process in cancer clinical trials...
  10. ncbi request reprint Recovery after stem-cell transplantation for hematologic diseases
    S J Lee
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 19:242-52. 2001
    ....
  11. ncbi request reprint Peace of mind and sense of purpose as core existential issues among parents of children with cancer
    J W Mack
    Children s Hospital Boston, Boston, MA Harvard School of Public Health, Boston, MA Yale School of Public Health, New Haven, CT Dana Farber Cancer Institute, Boston, MA
    J Clin Oncol 26:9518. 2008
    ..We sought to evaluate the core existential issues experienced by parents of children with cancer, and to determine factors that supported parents' ability to find peace of mind...
  12. ncbi request reprint Clinicopathological features and sites of recurrence according to breast cancer subtype in the National Comprehensive Cancer Network (NCCN)
    N U Lin
    Dana Farber Cancer Institute, Boston, MA City of Hope National Medical Center, Duarte, CA University of Texas M D Anderson Cancer Center, Houston, TX Roswell Park Cancer Institute, Buffalo, NY Fox Chase Cancer Center, Philadelphia, PA University of Michigan Cancer Center, Ann Arbor, MI
    J Clin Oncol 27:543. 2009
    ..543 Background: Gene expression profiling has defined multiple breast cancer subtypes which can approximated using standard immunohistochemical markers...
  13. ncbi request reprint Patient preferences concerning the trade-off between the risks and benefits of routine radiation therapy after conservative surgery for early-stage breast cancer
    J A Hayman
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    J Clin Oncol 15:1252-60. 1997
    ..To assess patients' preferences regarding the trade-off between risks and benefits of radiation therapy after conservative surgery for early-stage breast cancer...
  14. ncbi request reprint Discrepancies between patient and physician estimates for the success of stem cell transplantation
    S J Lee
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    JAMA 285:1034-8. 2001
    ..Stem cell transplantation is associated with considerable morbidity and mortality. The extent to which patients and their physicians correctly estimate these risks is unknown...
  15. ncbi request reprint Outcomes research in oncology: history, conceptual framework, and trends in the literature
    S J Lee
    Center for Outcomes and Policy Research, Department of Adult Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Natl Cancer Inst 92:195-204. 2000
    ..We suggest that as different branches of investigation develop their own literature and methodology-in effect, outgrowing the generic label of outcomes research-they become identified by separate, more precise terms...
  16. ncbi request reprint Understanding of prognosis among parents of children who died of cancer: impact on treatment goals and integration of palliative care
    J Wolfe
    Center for Outcomes and Policy Research and Department of Pediatric Oncology, Dana Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA
    JAMA 284:2469-75. 2000
    ..However, a more accurate understanding of prognosis could alter treatment goals and expectations and lead to more effective care...
  17. ncbi request reprint Predictors and effect of delay in initiation of radiation therapy (RT) after breast-conserving surgery (BCS) in elderly women
    R S Punglia
    Brigham and Women s Hospital, Boston, MA Dana Farber Cancer Institute, Boston, MA
    J Clin Oncol 26:6515. 2008
    ..6515 Background: The influence of time from BCS to initiation of RT on treatment outcomes is controversial. We sought to study predictors of delay in initiating RT and the influence of delay on breast cancer recurrence in elderly women...
  18. ncbi request reprint Discussion of treatment options for early-stage breast cancer: effect of provider specialty on type of surgery and satisfaction
    N L Keating
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    Med Care 39:681-91. 2001
    ..To describe the physicians with whom breast cancer patients discuss treatment options and assess whether discussing surgical options with a medical oncologist is associated with type of surgery and satisfaction...
  19. ncbi request reprint Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis
    C C Earle
    Center for Outcomes and Policy Research, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Clin Oncol 19:1064-70. 2001
    ..To compare the effectiveness of chemotherapy given to elderly patients in routine practice for stage IV non-small-cell lung cancer (NSCLC) with the efficacy observed in randomized trials...
  20. ncbi request reprint Binary data with two, non-nested sources of clustering: an analysis of physician recommendations for early prostate cancer treatment
    R A Betensky
    Department of Biostatistics, Harvard School of Public Health, 655 Huntington Avenue, Boston, MA 02115, USA
    Biostatistics 1:219-30. 2000
    ..We compare this model to a mixed-effects model that implicitly adjusts for both sources of clustering and to models based on the assumption of conditional independence with regard to one source of clustering...
  21. ncbi request reprint Pathologic characteristics of second breast cancers (SBC) among women previously treated for ductal carcinoma in situ (DCIS) with breast conservation
    N D Arvold
    Harvard Radiation Oncology Program, Boston, MA Dana Farber Cancer Institute, Boston, MA Brigham and Women s Hospital, Boston, MA Roswell Park Cancer Institute, Buffalo, NY University of Washington, Seattle, WA H Lee Moffitt Cancer Center and Research Institute, Tampa, FL City of Hope, Duarte, CA University of Texas M D Anderson Cancer Center, Houston, TX Fox Chase Cancer Center, Philadelphia, PA
    J Clin Oncol 29:1042. 2011
    ..1042 Background: While the number of women in the U.S. diagnosed with DCIS is increasing and many go on to develop SBC, pathologic characteristics of SBC and the degree of pathologic correlation with index DCIS are not well characterized...
  22. ncbi request reprint Factors associated with histologic versus cytologic diagnosis of lung cancer
    C S Lathan
    McGraw Patterson Center for Population Sciences Dana Farber Cancer Institute, Boston, MA Dana Farber Cancer Institute, Boston, MA
    J Clin Oncol 29:6048. 2011
    ..If there are differences in the likelihood of histologic diagnosis by race, ethnicity, or socioeconomic status (SES), it could contribute to disparities in lung cancer treatment and outcomes...
  23. ncbi request reprint Discussions about end-of-life care planning between physicians and patients with stage IV lung or colorectal cancer
    J W Mack
    Dana Farber Cancer Institute, Boston, MA Harvard Medical School, Boston, MA Greater Los Angeles Veterans Administration Health Care System and Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
    J Clin Oncol 29:6026. 2011
    ..We know little about the true incidence of EOL discussions or about where, when, or with whom they take place...
  24. ncbi request reprint Use of high-cost imaging in elderly patients with metastatic cancer
    Y Hu
    Brigham and Women s Hospital, Boston, MA Dana Farber Cancer Institute, Boston, MA Fred Hutchinson Cancer Research Center, Seattle, WA
    J Clin Oncol 29:6112. 2011
    ..We sought to determine patterns of imaging use in this population and to compare temporal trends with those observed among patients with curable early-stage disease...
  25. pmc What do patients value in their hospital care? An empirical perspective on autonomy centred bioethics
    S Joffe
    Department of Pediatric Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA
    J Med Ethics 29:103-8. 2003
    ..We sought to examine the relative influence of involvement in decisions, confidence and trust in providers, and treatment with respect and dignity on patients' evaluations of their hospital care...
  26. ncbi request reprint Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study
    J A Talcott
    Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA, USA
    J Clin Oncol 16:275-83. 1998
    ..To assess complications of therapy for early (nonmetastatic) prostate cancer...